InvestorsHub Logo
Followers 467
Posts 26906
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 21

Thursday, 09/15/2011 10:47:58 AM

Thursday, September 15, 2011 10:47:58 AM

Post# of 62
3:10AM Theravance and Astellas receive European Marketing Authorization for VIBATIV for nosocomial pneumonia caused by MRSA (THRX) 20.45 : Astellas Pharma Europe and co announce that the European Commission has granted marketing authorization for VIBATIV, following the Committee for Human Medicinal Products' positive opinion in May 2011. VIBATIV, discovered by THRX is a bactericidal, once-daily injectable lipoglycopeptide antibacterial agent with a dual mechanism of action against Gram-positive bacteria, including resistant pathogens such as methicillin-resistant Staphylococcus aureu


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THRX News